Stock listing
Firefly Neuroscience, Inc.
Selected listing: AIFF · NASDAQ · USD · US
Firefly Neuroscience, Inc. (NASDAQ:AIFF), Health Technology. Latest release Sep 25, 2026: Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access…
- Ticker
- NASDAQ:AIFF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Firefly Neuroscience, Inc.
The company focuses on advancements in neuroscience, aiming to develop innovative solutions in this field. Investors can find detailed information about the company's performance and strategic direction on its public page.
Latest news from Firefly Neuroscience, Inc.
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
September 25, 2026
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes
August 5, 2026
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
July 27, 2026
Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD
June 1, 2026
With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository
April 13, 2026
Research Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc. company profile
View the public company page for Firefly Neuroscience, Inc. on 6ix.
Firefly Neuroscience, Inc. news
Read company news and market updates connected to Firefly Neuroscience, Inc..
Firefly Neuroscience, Inc. investor events
Find investor webinars, events, and replay context for Firefly Neuroscience, Inc..